mecamylamine has been researched along with Encephalopathy, Toxic in 1 studies
Mecamylamine: A nicotinic antagonist that is well absorbed from the gastrointestinal tract and crosses the blood-brain barrier. Mecamylamine has been used as a ganglionic blocker in treating hypertension, but, like most ganglionic blockers, is more often used now as a research tool.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Qiao, D | 1 |
| Seidler, FJ | 1 |
| Violin, JD | 1 |
| Slotkin, TA | 1 |
1 other study available for mecamylamine and Encephalopathy, Toxic
| Article | Year |
|---|---|
Nicotine is a developmental neurotoxicant and neuroprotectant: stage-selective inhibition of DNA synthesis coincident with shielding from effects of chlorpyrifos.
Topics: Animals; Cell Differentiation; Cells, Cultured; Chlorpyrifos; Cholinesterase Inhibitors; DNA; Mecamy | 2003 |